GSA contract line item (1Q 2015): - $2.0 billion (announced Aug 2014): $187 million available - $3.0 to 5.0 million in unused funds: available to pain (VA)
Raise $8.0 million (2Q 2015):
$3.0 million bridge (4Q 2014) - $2.0 million – Pivotal Study (CIPN: 200 patients, multi-site, sham control) - $1.0 million – Operations (CMO and two nurses practitioners)
$5.0 million offering (2Q 2015) - $2.0 million – Pivotal Study (CRIPs, Failed Lower Back) - $1.5 million – R&D - $1.5 million – Operations
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.